NCT01814020View on ClinicalTrials.gov

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Distal Subungual Onychomycosis

Interventions

DRUG

MOB015B

Trial Locations (1)

SE-413 45

Hudkliniken Sahlgrenska Universitetssjukhuset, Gothenburg

Sponsors

Lead Sponsor

Moberg Pharma AB

All Listed Sponsors

lead

Moberg Pharma AB

INDUSTRY

NCT01814020 - An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) | Biotech Hunter | Biotech Hunter